Defect‐Engineering Bismuth‐Based Homologous Schottky Heterojunction for Metabolic Regulation‐Augmented Sonodynamic Tumor Therapy
Source abstract
Abstract
Abstract Sonodynamic therapy demonstrates tremendous potential in biomedicine due to its non‐invasiveness, deep tissue penetration, and spatiotemporal controllability. However, the lack of favorable nanosonosensitizers with prominent reactive oxygen species generation capability and green chemical constituents remains a significant challenge for its broad biomedical applications. Herein, a homologous bismuth‐based nanosonosensitizer (Bi‐HJ) is designed and fabricated by direct defect engineering for combinational tumor therapy. Specifically, self‐derived Schottky heterojunction and oxygen vacancies are concurrently constructed in Bi‐HJ, which prominently promotes the separation of ultrasound‐triggered electron–hole pairs and improves the charge utilization efficiency. With the porous structure, Bi‐HJ is loaded with a metabolic regulation drug atovaquone to block the mitochondrial respiration for oxygen‐economized sonodynamic tumor suppression. The strong near‐infrared absorption of Bi‐HJ imparted by oxygen vacancies allows the implementation of photothermal therapy. Accordingly, Bi‐HJ rationally combines two therapeutic modalities and metabolic regulation function, as well as computed tomography imaging ability, thus achieving effective tumor theranostics in vitro and in vivo. Therefore, this study provides new insight into the fabrication of homologous nanosonosensitizers without the introduction of other constituents for synergistically enhanced tumor therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Radiology Gongli Hospital of Shanghai Pudong New Area Shanghai 200135 P. R. China
School of Medicine Shanghai University Shanghai 200444 P. R. China
Materdicine Lab School of Life Sciences Shanghai University Shanghai 200444 P. R. China
School of Ophthalmology and Optometry Eye Hospital Wenzhou Medical University Wenzhou 325027 P. R. China
Funding
National Natural Science Foundation of China · Shanghai Shuguang Program
References (55)
Show source-provided references
1. 10.1038/s41467-021-25303-110.1038/s41467-021-25303-1 ↗
2. 10.1039/D1CS00403D10.1039/D1CS00403D ↗
3. Xing X. · Coord. Chem. Rev. · 2021 · 445
4. 10.1002/adma.20190073010.1002/adma.201900730 ↗
5. 10.1002/adma.20210033310.1002/adma.202100333 ↗
6. Qiu M. · Adv. Mater. · 2021 · 33
7. Cheng Y. · Adv. Mater. · 2020 · 32
8. 10.1002/adfm.20190859810.1002/adfm.201908598 ↗
9. 10.1038/s41467-022-30166-110.1038/s41467-022-30166-1 ↗
10. 10.1002/EXP.2021001010.1002/EXP.20210010 ↗
11. 10.1002/adfm.20190859810.1002/adfm.201908598 ↗
12. 10.1021/acsnano.2c0254010.1021/acsnano.2c02540 ↗
13. 10.1016/j.nantod.2021.10110410.1016/j.nantod.2021.101104 ↗
14. 10.1002/smll.20220308010.1002/smll.202203080 ↗
15. 10.1002/adma.20210146710.1002/adma.202101467 ↗
16. 10.1002/smll.20210352810.1002/smll.202103528 ↗
17. 10.1021/acsnano.2c0217710.1021/acsnano.2c02177 ↗
18. 10.1016/j.cej.2022.13555810.1016/j.cej.2022.135558 ↗
19. 10.1016/j.biomaterials.2020.12007510.1016/j.biomaterials.2020.120075 ↗
20. 10.1016/j.biomaterials.2021.12078710.1016/j.biomaterials.2021.120787 ↗
21. 10.1021/acsnano.2c0790310.1021/acsnano.2c07903 ↗
22. 10.1038/nchem.60910.1038/nchem.609 ↗
23. 10.1039/C9CS00283A10.1039/C9CS00283A ↗
24. 10.1002/adhm.20190169510.1002/adhm.201901695 ↗
25. 10.1021/acsnano.0c0245810.1021/acsnano.0c02458 ↗
26. Song M. · Adv. Funct. Mater. · 2020 · 30
27. Dong Y. · Adv. Mater. · 2021 · 33
28. Yang Z. · Angew. Chem., Int. Ed. · 2022 · 61
29. 10.1016/j.biomaterials.2018.04.02210.1016/j.biomaterials.2018.04.022 ↗
30. Huang X. · Adv. Funct. Mater. · 2022 · 32
31. 10.1016/j.scib.2020.01.00710.1016/j.scib.2020.01.007 ↗
32. 10.1016/j.actbio.2021.05.01610.1016/j.actbio.2021.05.016 ↗
33. 10.1016/j.apcatb.2020.11895710.1016/j.apcatb.2020.118957 ↗
34. Li Y. · Angew. Chem., Int. Ed. · 2020 · 60
35. 10.1021/acsnano.0c0523510.1021/acsnano.0c05235 ↗
36. 10.1002/adfm.20180729410.1002/adfm.201807294 ↗
37. 10.1016/j.cej.2020.12691010.1016/j.cej.2020.126910 ↗
38. 10.1016/j.apcatb.2018.09.03210.1016/j.apcatb.2018.09.032 ↗
39. 10.1016/j.jcat.2017.04.02510.1016/j.jcat.2017.04.025 ↗
40. 10.1039/C8QM00221E10.1039/C8QM00221E ↗
41. 10.1007/s40820-022-00832-610.1007/s40820-022-00832-6 ↗
42. 10.1021/acs.nanolett.1c0205310.1021/acs.nanolett.1c02053 ↗
43. 10.1016/j.apcatb.2017.07.03010.1016/j.apcatb.2017.07.030 ↗
44. 10.1002/chem.20170616410.1002/chem.201706164 ↗
45. 10.1016/j.ensm.2020.02.02710.1016/j.ensm.2020.02.027 ↗
46. 10.1002/adhm.20210250310.1002/adhm.202102503 ↗
47. 10.1021/acsnano.1c0802610.1021/acsnano.1c08026 ↗
48. 10.1002/smll.20210455010.1002/smll.202104550 ↗
49. 10.1021/acsnano.1c0312810.1021/acsnano.1c03128 ↗
50. 10.1002/smll.20210352810.1002/smll.202103528 ↗
51. 10.1038/s41467-021-24961-510.1038/s41467-021-24961-5 ↗
52. 10.1021/jacs.7b0781810.1021/jacs.7b07818 ↗
53. 10.1002/anie.20201633010.1002/anie.202016330 ↗
54. 10.1021/acs.nanolett.0c0004710.1021/acs.nanolett.0c00047 ↗
55. Huang J.‐Q. · Small · 2022 · 18